DOSE-INDEPENDENT PHARMACOKINETICS OF THE
β
John R. Baldwin; Richard C. Lewis; Barbara A. Phillips; Stephen K. Overmyer; Nao
π
Article
π
1996
π
John Wiley and Sons
π
English
β 581 KB
A randomized, four-way cross-over design was used to assess the disposition of the cardioprotective agent, dexrazoxane, in four male beagle dogs following single I.V. administration of 10, 25, 50, and 100mgkg-l doses. Parent drug was quantified in plasma and urine with a validated high-pressure liqu